Our news

1655 news items

Research

SAPPHIRE trial starts at I-Motion

On 30/11/2022

The SAPPHIRE trial is an international, randomised, double-blind, placebo-controlled phase III trial that will evaluate the effects of a dual treatment : apitegromab (an anti-myostatin…

Research

Masseter muscle volume as a biomarker in DM1?

On 29/11/2022

In the context of therapeutic trials in development for myotonic dystrophy type 1 (DM1), the search for reliable and relevant clinical or paraclinical criteria is…

Research

Exoskeleton and SMA: first feedback

On 22/11/2022

An exoskeleton is a complex and sophisticated piece of equipment that can partially compensate for a person’s motor deficiencies in the context of paralysis. Spanish…